Haesukpark

A $3.3 million grant from the National Institute on Drug Abuse will fund the development of the hepatitis C screening tool.

Haesuk Park and her colleagues developed four machine-learning algorithms to predict direct-acting antiviral treatment failure among hepatitis C patients.

The University of Florida College of Pharmacy celebrates women advancing the pharmaceutical sciences during the fifth International Day of Women and Girls in Science on Feb. 11. Five female faculty members and five graduate students were asked to share a message with aspiring young, female pharmaceutical scientists.

The study, published in the journal Hepatology, examined the clinical and economic outcomes of direct-acting antiviral therapy, which cures hepatitis C in nearly 95 percent of patients.